首页> 外文OA文献 >Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

【2h】

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

机译：39例接受伊马替尼治疗类固醇难治性慢性GVHD的患者的NIH反应标准的长期结果和前瞻性验证。

页面导航

著录项
相似文献
相关主题

著录项

作者
Olivieri A; Cimminiello M; Corradini P; Mordini N; Fedele R; Selleri C; Onida F; Patriarca F; Pavone E; Svegliati S; Gabrielli A; Bresciani P; Nuccorini R; Pascale S; Coluzzi S; Pane F; Poloni A; Olivieri J; Leoni P; Bacigalupo A;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD [J] . OlivieriA., CimminielloM., CorradiniP., Blood: The Journal of the American Society of Hematology . 2013,第25期

机译：接受伊马替尼治疗顽固性顽固性慢性GVHD的39例患者的NIH反应标准的长期结果和前瞻性验证
2. Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD. [J] . Jacobsohn DA, Rademaker A, Kaup Bone marrow transplantation . 2009,第12期

机译：在一项针对类固醇难治性慢性GVHD的II期研究中，使用NIH共识标准与Hopkins量表的皮肤反应。
3. Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria) [J] . Olivieri A., Mancini G., Olivieri J., Bone marrow transplantation . 2020,第11期

机译：尼洛替尼在类固醇 - 难治性CGVHD中：根据NIH标准和探索性响应标准（Gitmo标准）的响应预期并行评估（Gitmo标准）
4. The results of the long-term prospective study of primary chronic septic endocarditis in patients with bivalvular valvulitis [C] . Bushmanova G., Nepomnyashchikh L., Zorina I. World Asthma COPD Forum . 2013

机译：双慢性血管炎患者原发性慢性脓毒症心内膜炎长期前瞻性研究结果
5. Prospective evaluation of serum vitamin B12 levels in patients receiving long-term lansoprazole for gastroesophageal reflux disease. [D] . Sotiriou, Christopher Gus. 2000

机译：长期接受兰索拉唑治疗胃食管反流病患者的血清维生素B12水平的前瞻性评估。
6. Clinical Trials and Observations: European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor [O] . David Marin, Dragana Milojkovic, Eduardo Olavarria, -1

机译：临床试验和观察：欧洲白血病针对失败或次优反应的NetNet标准可靠地确定了接受伊马替尼治疗的慢性晚期早期CML患者其最终结果较差
7. Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD [O] . Olivieri Attilio, Cimminiello Michele, Corradini Paolo, 2013

机译：接受伊马替尼治疗顽固性顽固性慢性GVHD的39例患者的NIH反应标准的长期结果和前瞻性验证

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.

著录项

相似文献

相关主题

期刊订阅